# Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

> **NCT02385526** · — · COMPLETED · sponsor: **Cyberonics, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Epilepsy
- Seizures

## Interventions

- **DEVICE:** Vagus Nerve Stimulation Therapy

## Key facts

- **NCT ID:** NCT02385526
- **Lead sponsor:** Cyberonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-28
- **Primary completion:** 2016-10-10
- **Final completion:** 2016-10-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385526, "Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02385526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*